News
Updates from the lab and beyond.
Milestones, publications, and partnerships as we work toward a universal blood supply.
BioIchor opens a Series A founding campaign to advance universal blood platform
With the aim of reducing operating time and increasing automation
↗
Innovative Fab Technology for Rh(D) Immune Shielding
New paper in Nature Biotechnology details the science behind ICHOR-1.
↗
Strategic collaboration with Dr. Hannibal Lecter
Use of our platform in several hospitals in Baltimore
↗
First-in-human transfusion of converted O‑negative red cells
Phase I dose-escalation initiated under an active IND.
↗